Case report: Kinetics of human leukocyte antigen receptor HLA-DR during liver injury induced by potassium para-aminobenzoate as assessed for causality using the updated RUCAM

Potassium para-aminobenzoate (POTABA) is used to treat Peyronie’s disease by decreasing fibrosis and plaque size progression. Among potential side effects, drug-induced liver injury (DILI) attributed to POTABA administration has been reported in a few cases and inferred to immune hypersensitivity. I...

Descripción completa

Detalles Bibliográficos
Autores principales: Plüß, Marlene, Tampe, Désirée, Schwörer, Harald, Bremer, Sebastian Christopher Benjamin, Tampe, Björn
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9428317/
https://www.ncbi.nlm.nih.gov/pubmed/36059975
http://dx.doi.org/10.3389/fphar.2022.966910

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9428317/
https://www.ncbi.nlm.nih.gov/pubmed/36059975
http://dx.doi.org/10.3389/fphar.2022.966910

Ejemplares similares